SCOPUS 정보 검색 플랫폼

Human Psychopharmacology: Clinical and Experimental

Volumn 10, Issue 2 S, 1995, Pages S97-S106

Pharmacokinetic dose‐proportionality study at steady state of mirtazapine from Remeron® tablets

(3) Timmer, C J a Lohmann, A A M b Mink, C P A a

a Department of Drug Metabolism and Kinetics ^* (Netherlands)

b Thiemann Arzneimittel GmbH (Germany)

Author keywords

antidepressant; dose proportionality; mirtazapine; Org 3770; Remeron

Indexed keywords

ANTIDEPRESSANT AGENT; MIRTAZAPINE; NEW DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PRIORITY JOURNAL; STEADY STATE; VOLUNTEER;

EID: 0029074770 PISSN: 08856222 EISSN: 10991077 Source Type: Journal
DOI: 10.1002/hup.470100804 Document Type: Article

Times cited : (50)

References (15)

1
- 0026684148
- The effect of noradrenergic drugs on serotonin metabolism in the nucleus raphe dorsalis of the rat, studied by in vitro voltametry
- (1992) European Journal of Pharmacology , vol.217 , pp. 43-48
- Clement, H.H.¹ Gemsa, D.² Weseman, W.³

2
- 84987563707
- Note for Guidance, Investigation of Bioavailability and Bioequivalence. III/54/89‐EN.
- (1991)

3
- 0028181238
- 2 antagonist Org 3770 enhances serotonin transmission in vivo
- R5, 6
- (1994) European Journal of Pharmacology , vol.253
- De Boer, T.¹ Nefkens, F.² Van Helvoirt, A.³

4
- 84987466267
- The selective α2‐adrenoreceptor antagonist Org 3770 (mirtazapine). enhances noradrenergic and serotonin1A‐mediated serotonergic neurotransmission. CNS Drugs
- (1995)
- De Boer, T.¹ Ruigt, G.S.F.²

5
- 0021798601
- A set of behavioural tests predicting antidepressant activity
- Drug Development Research , vol.5 , pp. 291-301
- De Graaf, J.S.¹ Berendsen, H.M.G.² Van Riezen, H.³

6
- 84987522905
- N. V. Organon, Oss, The Netherlands
- Biotransformation of Org 3770 in man and laboratory animals. Data on file
- Delbressine, L.P.C.¹ Moonen, M.E.G.² Kaspersen, F.M.³ Wagenaars, G.N.⁴

7
- 84988072851
- 14C
- (1989) Journal of Labelled Compounds and Radiopharmaceuticals , vol.27 , pp. 1055-1068
- Kaspersen, F.M.¹ Van Rooij, A.A.M.² Sperling, E.G.M.³ Wieringa, J.H.⁴

8
- 84987486880
- N. V. Organon, Oss, The Netherlands
- (1992) Validation of the gas chromatographic assay for the determination of Org 3770 in human plasma. Data on File
- Lohmann, A.¹ Dingler, E.² Diekmann, N.³

9
- 0027981186
- Safety and efficacy during long‐term treatment with Moclobemide
- (1994) Clinical Neuropharmacology , vol.17 , pp. S74
- Moll, E.¹ Neumann, N.² Schmid‐Burgk, W.³

10
- 0009868362
- SAS Institute Inc., Cary, N. C.
- (1989) SAS User's Guide, Version 6.06

11
- 0027159399
- Fluoxetine: a five‐year review
- (1993) Clinical Therapeutics , vol.15 , pp. 216-243
- Stokes, P.E.¹

12
- 84987494327
- Statistical procedures for bioequivalence studies using a standard two‐treatment crossover design. Statement under 21 CFR 10.90.
- (1992)
- Food, U.S.¹

13
- 0015135137
- The effect of a number of drugs with different pharmacological properties upon reserpine induced hypothermia in mice
- (1971) Arzneimittel Forsch , vol.22 , pp. 1562-1566
- Van Riezen, H.¹ Delver, A.²

14
- 84987518632
- Bioavailability of mirtazapine from Remeron® tablets after single and multiple oral dosing. (Submitted).
- (1995)
- Voortman, G.¹ Paanakker, J.E.²

15
- 0027471867
- A double‐blind comparison of moclobemide and fluoxetine in the treatment of depressive disorders
- (1993) International Clinical Psychopharmacology , vol.7 , pp. 155-158
- Williams, R.¹ Edwards, R.A.² Newburn, G.M.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.